Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps

Purpose To evaluate epiretinal membrane (ERM) removal utilizing internal limiting membrane (ILM) forceps and visualization with triamcinolone acetonide (TA). Methods Retrospective interventional case series of eyes undergoing ERM removal with TA visualization with follow-up of up to five years. Best-corrected visual acuity (BCVA), central macular thickness (CMT), and incidence of complications were reviewed. Results A total of 132 eyes were included with 54 and 16 eyes completing 3- and 5-year follow-up, respectively. Mean BCVA and CMT improved significantly at all postoperative evaluations compared to baseline (p<0.001). Pre-operative presence of PVD did not affect outcome measures. No intraoperative complications were reported. Immediate post-operative complications included one case of sterile endophthalmitis and one case of vitreous and perimacular hemorrhage. At one year, complications included progression of cataract in phakic eyes (65.4%), steroid-induced glaucoma (2.2%), retinal tear (0.8%), recurrent ERM (4.5%), and recurrent macular edema (11.3%). No further complications were reported at three- and five-year follow-up. Conclusion Combination ILM forceps and TA visualization offers an affordable and safe option for ERM removal with comparable or better outcomes than traditional methods of ERM surgery.

[1]  H. Scholl,et al.  Outcomes after Epiretinal Membrane Surgery with or Without Internal Limiting Membrane Peeling , 2019, Ophthalmology and Therapy.

[2]  C. Wykoff,et al.  Five-Year Outcomes of Surgically Treated Symptomatic Epiretinal Membranes With and Without Internal Limiting Membrane Peeling. , 2018, Ophthalmic surgery, lasers & imaging retina.

[3]  T. Katome,et al.  Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy , 2018, British Journal of Ophthalmology.

[4]  A. Barak,et al.  FIVE-YEAR FOLLOW-UP AFTER EPIRETINAL MEMBRANE SURGERY: A Single-Center Experience , 2017, Retina.

[5]  S. Gotzaridis,et al.  Long Term Outcomes after Pars Plana Vitrectomy for the Treatment of Epiretinal Membranes , 2016 .

[6]  H. Flynn,et al.  Macular toxicity following brilliant blue G-assisted macular hole surgery - a report of three cases. , 2014, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH.

[7]  C. Ehlken,et al.  Intra- and Postoperative Risks and Complications of Small-Gauge (23-G) versus Conventional (20-G) Vitrectomy for Macular Surgery , 2014, European journal of ophthalmology.

[8]  T. Williamson,et al.  Visual acuity outcomes following surgery for idiopathic epiretinal membrane: an analysis of data from 2001 to 2011 , 2014, Eye.

[9]  P. Barale,et al.  EPIRETINAL MEMBRANE RECURRENCE: Incidence, Characteristics, Evolution, and Preventive and Risk Factors , 2013, Retina.

[10]  H. Tabandeh,et al.  Triamcinolone Acetonide (TA) Assisted Removal of Internal Limiting Membrane (ILM) , 2013 .

[11]  A. Melamud,et al.  SURGICAL OUTCOMES IN PATIENTS WITH MACULAR PUCKER AND GOOD PREOPERATIVE VISUAL ACUITY AFTER VITRECTOMY WITH MEMBRANE PEELING , 2012, Retina.

[12]  Christos Haritoglou,et al.  RESIDUAL CELLULAR PROLIFERATION ON THE INTERNAL LIMITING MEMBRANE IN MACULAR PUCKER SURGERY , 2012, Retina.

[13]  K. Ramasamy,et al.  A COMPARISON OF BRILLIANT BLUE G, TRYPAN BLUE, AND INDOCYANINE GREEN DYES TO ASSIST INTERNAL LIMITING MEMBRANE PEELING DURING MACULAR HOLE SURGERY , 2011, Retina.

[14]  T. Hisatomi,et al.  Brilliant blue G for ILM staining and peeling: This potent stain is easy to handle and safe, with minimal side effects , 2011 .

[15]  Y. Mizutani,et al.  Double staining with brilliant blue G and double peeling for epiretinal membranes. , 2009, Ophthalmology.

[16]  S. Priglinger,et al.  VITAL DYES FOR MACULAR SURGERY: A Comparative Electron Microscopy Study of the Internal Limiting Membrane , 2009, Retina.

[17]  S. Bakri,et al.  Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous , 2008, Clinical ophthalmology.

[18]  T. Sakamoto,et al.  One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  A. Uemura,et al.  LONG-TERM OUTCOMES OF MACULAR HOLE SURGERY WITH TRIAMCINOLONE ACETONIDE–ASSISTED INTERNAL LIMITING MEMBRANE PEELING , 2007, Retina.

[20]  S. Mennel,et al.  MECHANISMS OF INTRAVITREAL TOXICITY OF INDOCYANINE GREEN DYE: Implications for Chromovitrectomy , 2007, Retina.

[21]  Y. Hata,et al.  Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. , 2007, Ophthalmology.

[22]  G. Somfai,et al.  Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. , 2006, American journal of ophthalmology.

[23]  T. Sakamoto,et al.  VITREOMACULAR ADHESION AND THE DEFECT IN POSTERIOR VITREOUS CORTEX VISUALIZED BY TRIAMCINOLONE-ASSISTED VITRECTOMY , 2005, Retina.

[24]  P. Beaumont,et al.  Visual outcomes following vitrectomy and peeling of epiretinal membrane , 2005, Clinical & experimental ophthalmology.

[25]  Y. Hata,et al.  Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. , 2004, American journal of ophthalmology.

[26]  Z. Gregor,et al.  Acute macular pucker. , 2003, Ophthalmology.

[27]  T. Hisatomi,et al.  Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  G. Peyman,et al.  TRIAMCINOLONE ACETONIDE AS AN AID TO VISUALIZATION OF THE VITREOUS AND THE POSTERIOR HYALOID DURING PARS PLANA VITRECTOMY , 2000, Retina.

[29]  A. Kampik,et al.  Ultrastructure of epiretinal membranes associated with macular holes , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.

[30]  W. Green,et al.  Histopathology of tissue removed during vitrectomy for impending idiopathic macular holes. , 1989, American journal of ophthalmology.

[31]  R. Michels.  VITREOUS SURGERY FOR MACULAR PUCKER , 1981, American journal of ophthalmology.

[32]  Masayuki Horiguchi,et al.  Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. , 2005, Archives of ophthalmology.